BioCardia Financials - Benzinga

BioCardia Inc

BCDANASDAQ

Trade with Public

Trade with Public

$1.08

-0.01-0.92%

At close: Sep 4, 5:00 PM EST

$1.06

-0.0199-1.84%

After Hours: Sep 4, 7:33 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

BioCardia Financials

BioCardia (BCDA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
BioCardia Q2 EPS $(0.13) Beats $(0.18) Estimate

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.18) by 27.78 percent. This is a 67.5 percent increase over losses of $(0.40) per share from the

Benzinga Newsdesk

PRO
BioCardia Q1 EPS $(0.21) Misses $(0.17) Estimate

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.17) by 23.53 percent. This is a 64.41 percent increase over losses of $(0.59) per share from the

Benzinga Newsdesk

Earnings Scheduled For May 15, 2026

Benzinga Insights

PRO
BioCardia Q4 EPS $(0.06) Beats $(0.17) Estimate

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.17) by 64.71 percent. This is a 76 percent increase over losses of $(0.25) per share from the same

Benzinga Newsdesk

Earnings Scheduled For March 24, 2026

Benzinga Insights

PRO
BioCardia Q3 EPS $(0.24) Beats $(0.25) Estimate

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.25) by 4 percent. This is a 60.66 percent increase over losses of $(0.61) per share from the same

Benzinga Newsdesk